The reduced ACE2 levels following SARS-CoV infection led to acute lung injury, and interestingly, the lung injury was significantly attenuated in ACE2 knockout mice and angiotensin II type 1 receptor blocker (ARB) treated groups [38]. The gene discussed is ACE2; the disease is severe acute respiratory syndrome.